PneumaCare company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

pneumacare.com

Stage

Series B | Alive

Total Raised

$4.44M

Last Raised

$1.6M | 9 yrs ago

About PneumaCare

PneumaCare is a Cambridge (UK)-based company providing clinicians with respiratory diagnostic and monitoring equipment using non-invasive 3D-imaging technology. Thora-3DI and PneumaScan are CE mark approved and are already being used in clinics, pre- and post-operative assessments, drug testing, and device development by both public and private health care providers. Further applications of PneumaCare's Structured Light Plethysmography technology, developed in close partnership with the clinical community, include home care, neonatal, critical care, and rehabilitation applications.

PneumaCare Headquarter Location

St. John’s Innovation Centre Cowley Road

Cambridge, England, CB4 0WS,

United Kingdom

+44 1223 703 151

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing PneumaCare

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

PneumaCare is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

11,001 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,900 items

PneumaCare Patents

PneumaCare has filed 4 patents.

The 3 most popular patent topics include:

  • Abdomen
  • Mechanical ventilation
  • Pulmonology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/27/2018

8/27/2019

Respiratory therapy, Mechanical ventilation, Respiratory physiology, Pulmonology, Abdomen

Grant

Application Date

8/27/2018

Grant Date

8/27/2019

Title

Related Topics

Respiratory therapy, Mechanical ventilation, Respiratory physiology, Pulmonology, Abdomen

Status

Grant

Latest PneumaCare News

Thora-3DI Contact-Free Lung Performance Analysis System FDA Cleared

Mar 22, 2016

March 22nd, 2016 Editors Cardiology , Medicine , Thoracic Surgery PneumaCare, a firm based in Cambridgeshire, England, announced FDA clearance of its Thora-3DI contact-free breath assessment system. The product shines a black and white checkerboard grid onto the patient’s chest which allows it to make 3D recordings of the chest wall motion. It detects chest movement with an accuracy down to .25 mm and naturally provides highly accurate respiration rate readings. The technology within the Thora-3DI is called Structured Light Plethysmography (SLP) and using it clinicians can spot differences between the left and right lung movement, how the chest and abdomen correlate, and other similar issues. Accompanying software provides in-depth analysis of  the readings and provides 3D visualization of the chest movement during the recordings. Some more details according to the product page: PneumaCare’s software provides the operator with the ability to divide the image into defined regions for comparison of the patient’s symmetry of breathing. These regional contributions can be analysed by comparing the upper chest and abdomen or the left and right sides of the chest; detailing potential asymmetries that are indicative of respiratory-related issues. By measuring the chest wall, the Thora-3DI™ can show the clinician the dynamics of lung function in real time, reflecting respiratory function, and divide that performance data into various regional assessments for comparison. This provides a deeper understanding of the patient’s lung function. Using Thora-3DI™, the  clinician can understand objectively – qualitatively and quantitatively – not only the patient’s lung performance symmetries but also the change of that performance over time. This can be done without the need of forced manoeuver testing or movement of the patient to a measurement site. Moreover, the patient can be sitting or lying, conscious or unconscious because Thora-3DI™ is non-invasive and does not require any direct interaction with the patient.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.